Personalized cancer vaccine after surgery for solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a personalized vaccine designed to train your immune system to fight any remaining cancer cells after surgery or during standard therapy. It is for people with solid tumors who are stable and have no signs of disease getting worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are able to take care of yourself (ECOG score 0-1).
- Your doctor expects you to live at least 6 more months.
- You have a solid tumor and are getting treatment before or after surgery, or your cancer has spread but is stable.
- Your cancer has not gotten worse in the last 28 days.
- Your major organs (like kidneys and liver) are working well enough.
- If you could become pregnant, you agree to use effective birth control and not breastfeed during and for 90 days after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized cancer vaccine made from synthetic long peptide “neoantigens,” aiming to be safe and help the immune system fight certain solid tumors. It may fit people with pancreatic cancer after starting first-line chemotherapy, and some other solid tumors with limited options.
This trial tests a personalized vaccine made from your own cells to help your immune system attack tumor-specific targets. It may be an option if standard treatments have stopped working or caused side effects you can't tolerate.
This trial tests a personalized vaccine made from your own tumor's genetic information. The vaccine is given after surgery to try to train your immune system to fight any remaining cancer cells and reduce the chance of the cancer coming back.
This trial tests a personalized cancer vaccine, made specifically for your tumor, combined with a medicine called toripalimab (which helps your immune system fight cancer). It is designed for people who have had surgery for a solid tumor and are getting additional therapy to try to prevent the cancer from coming back.
This trial tests a personalized cancer vaccine, given alone or with an immunotherapy drug called toripalimab, in people with non-small cell lung cancer (NSCLC) who have had surgery and are getting adjuvant therapy (treatment to prevent the cancer from coming back). The goal is to see if the vaccine is safe and may help the immune system fight any remaining cancer cells.
This trial tests a new investigational drug called ABO2011, which is injected directly into tumors. It is for people with advanced solid tumors that have not responded to previous treatments. The goal is to see if the drug is safe and can help shrink or slow tumor growth.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.